Developed by the Korean medical aesthetics and biotech company Medytox in 2006, and derived from the original bacterial strain from the University of Wisconsin in the United States, Miracle Botulinum Toxin is the first botulinum toxin brand to be developed and marketed in Korea, and is also the best-selling brand in the country. Miracle Botulinum Toxin is a protein extracted from the secretion and purification of botulinum toxin, which can inhibit the release of nerve signals, relax designated muscle areas, reduce muscle action, reduce dynamic wrinkles, restore smoothness, and prevent the formation of new fine lines, thus achieving anti-aging effects.
One to two days after the surgery, the effects of the botulinum toxin will gradually become apparent, and during the process, one may feel that the muscles are sore and soft, while fine lines will begin to disappear. About two to three weeks after the surgery, the effect will reach its peak, revealing smooth and flawless youthful skin.
Any neuro-transmission disease related to acetylcholine release can be treated with botulinum toxin. Currently, there are more than 200 indications for its use. Due to the high safety and stable effectiveness of botulinum toxin, it is widely used in the field of medical aesthetics. The most common applications include: